118 related articles for article (PubMed ID: 15865597)
1. Effectiveness and side effects of thiazolidinediones for type 2 diabetes.
Morton AP; McIntyre HD
Med J Aust; 2005 May; 182(9):492-3. PubMed ID: 15865597
[No Abstract] [Full Text] [Related]
2. [New rank order of antidiabetic drugs. Using glitazone before sulfonylurea drugs? (interview by Dr. Dirk Einecke)].
Jacob S
MMW Fortschr Med; 2007 Jan; 149(1-2):14. PubMed ID: 17632857
[No Abstract] [Full Text] [Related]
3. Cancer and bone fractures in observational follow-up of the RECORD study.
Jones NP; Curtis PS; Home PD
Acta Diabetol; 2015 Jun; 52(3):539-46. PubMed ID: 25524432
[TBL] [Abstract][Full Text] [Related]
4. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
5. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ
Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
[No Abstract] [Full Text] [Related]
7. [Sulfonylurea-pioglitazone combination agent].
Hashiramoto M; Kaku K
Nihon Rinsho; 2012 May; 70 Suppl 3():633-41. PubMed ID: 22768590
[No Abstract] [Full Text] [Related]
8. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
[No Abstract] [Full Text] [Related]
9. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
Nauck MA; Matthaei S
Dtsch Med Wochenschr; 2005 Apr; 130(17):1091-6. PubMed ID: 15841424
[No Abstract] [Full Text] [Related]
10. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
11. Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA).
Karamanos B; Thanopoulou A; Drossinos V; Charalampidou E; Sourmeli S; Archimandritis A;
Curr Med Res Opin; 2011 Feb; 27(2):303-13. PubMed ID: 21142615
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
[TBL] [Abstract][Full Text] [Related]
13. Preventing type 2 diabetes with low-dose combinations.
Buchanan TA; Xiang AH
Lancet; 2010 Jul; 376(9735):72-4. PubMed ID: 20605203
[No Abstract] [Full Text] [Related]
14. Adverse effect of pioglitazone in military personnel and their families: a preliminary report.
Vudhironarit T; Benjasuratwong Y; Patarakitvanit S; Temboonkiat S; Satyapan N
J Med Assoc Thai; 2009 Feb; 92 Suppl 1():S124-8. PubMed ID: 21299185
[TBL] [Abstract][Full Text] [Related]
15. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
16. The UK Prospective Diabetes Study.
Evans M
Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
[No Abstract] [Full Text] [Related]
17. The UK Prospective Diabetes Study.
Bailey CJ; Grant PJ
Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806
[No Abstract] [Full Text] [Related]
18. A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
Chang Y; Choi NK; Hahn S; Park BJ
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1072-3; author reply 1073-4. PubMed ID: 17907252
[No Abstract] [Full Text] [Related]
19. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
20. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
